Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disease (NMOSD)”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Not applicableStudy completedNCT07032337
What this trial is testing

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Samsung Medical Center 2,985
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Not applicableEnded earlyNCT04131764
What this trial is testing

Diagnosis of ON With or Without MS or NMOSD

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum Disorder AttackNeuromyelitis Optica Spectrum Disorder Relapse+2 more
Jagannadha R Avasarala 112
Large-scale testing (Phase 3)Not Yet RecruitingNCT07132398
What this trial is testing

Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD

Who this might be right for
Neuromyelitis Optica (NMO)Neuromyelitis Optica Spectrum Disorders (NMOSD)
Tianjin Medical University General Hospital 170
Early research (Phase 1)Not Yet RecruitingNCT07573332
What this trial is testing

A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients

Who this might be right for
AQP4+ NMOSD
University of Texas Southwestern Medical Center 5
Large-scale testing (Phase 3)Study completedNCT04660539
What this trial is testing

Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Hoffmann-La Roche 119
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Not applicableLooking for participantsNCT06865274
What this trial is testing

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Large-scale testing (Phase 3)Study completedNCT02073279
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 95
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Very early researchNot Yet RecruitingNCT07592754
What this trial is testing

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital 18
Large-scale testing (Phase 3)Looking for participantsNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT03452176
What this trial is testing

Scrambler Trial for Pain in NMOSD

Who this might be right for
Neuromyelitis Optica
Johns Hopkins University 22
Not applicableNot Yet RecruitingNCT07159893
What this trial is testing

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Who this might be right for
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
First Affiliated Hospital of Wenzhou Medical University 25
Post-approval studies (Phase 4)Ended earlyNCT05269667
What this trial is testing

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06557174
What this trial is testing

Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. 116
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138
What this trial is testing

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 135
Testing effectiveness (Phase 2)Study completedNCT03062579
What this trial is testing

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaDevic's Disease
Fu-Dong Shi 10
Not applicableNot Yet RecruitingNCT07304960
What this trial is testing

Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder (NMOSD)
Assiut University 100
Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Load More Results